Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Bronx, New York 10468


This study seeks to examine the efficacy of hydrocortisone administration in the augmentation of the therapeutic effects of Prolonged Exposure (PE) therapy, an empirically tested treatment shown to be effective in the the treatment of posttraumatic stress disorder (PTSD). The augmentation builds on both the translation of neuroscience findings demonstrating the effects of glucocorticoids (GCs) on learning, and on empirical clinical findings from other investigators demonstrating beneficial effects of GCs in reducing traumatic memories in trauma-exposed persons.


Inclusion Criteria: - Veterans who experienced a criterion A trauma while deployed, and a current diagnosis of PTSD with a minimum of 6 months - Capable of understanding, reading and writing English Exclusion Criteria: - Incapable and/or unwilling to provide written informed consent prior to participation - Unwilling and/or unable to discontinue current psychotherapy - Regular use of psychotropic medication including antidepressants, benzodiazepines, lithium, mood stabilizers, over-the-counter supplements (melatonin, kava-kava, ephedra) - Regular use of oral or inhaled steroids - Significant illness (e.g., type I or II diabetes requiring the use of insulin, HIV, AIDS, seizure disorder, anemia, Lyme disease, etc.) - The veteran, the veteran's physician, or the study physician think that the veteran's clinical state necessitates the prompt initiation of pharmacotherapy or other treatment that would preclude involvement in the study - Morbid obesity (VMI > 40) - Clinically significant laboratory abnormalities as determine during medical clearance procedures - For women, a positive pregnancy test - Heavy smoking (more than 2 packs a day) - Substance and/or alcohol abuse and/or dependence within the previous 6 months - Response of 3 or 4 on the suicidality items of the HDRS or an assessed serious suicide risk - Current psychosocial problems that might interfere with treatment compliance - A lifetime history of schizophrenia, schizoaffective disorder, bipolar disorder, obsessive compulsive disorder or PTSD due to a trauma not sustained in the combat theater



Primary Contact:


Backup Contact:


Location Contact:

Bronx, New York 10468
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.